Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy

Por Thomas, Scott, Thurn, Kenneth T., Biçaku, Elona, Marchion, Douglas C., Münster, Pamela N.
Publicado em 2011

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition

Por Turner, Joel G., Marchion, Douglas C., Dawson, Jana L., Emmons, Michael F., Hazlehurst, Lori A., Washausen, Peter, Sullivan, Daniel M.
Publicado em 2009

Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer

Por BOU ZGHEIB, NADIM, MARCHION, DOUGLAS C., BUSH, STEPHEN H., JUDSON, PATRICIA L., WENHAM, ROBERT M., APTE, SACHIN M., LANCASTER, JOHNATHAN M., GONZALEZ-BOSQUET, JESUS
Publicado no Oncol Lett (2016)

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

Por Bansal, Nisha, Marchion, Douglas C., Bicaku, Elona, Xiong, Yin, Chen, Ning, Stickles, Xiaomang B., Sawah, Entidhar Al, Wenham, Robert M., Apte, Sachin M., Gonzalez-Bosquet, Jesus, Judson, Patricia L., Hakam, Ardeshir, Lancaster, Johnathan M.
Publicado em 2012

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

Por CHEN, NING, CHON, HYE SOOK, XIONG, YIN, MARCHION, DOUGLAS C., JUDSON, PATRICIA L., HAKAM, ARDESHIR, GONZALEZ-BOSQUET, JESUS, PERMUTH-WEY, JENNIFER, WENHAM, ROBERT M., APTE, SACHIN M., CHENG, JIN Q., SELLERS, THOMAS A., LANCASTER, JOHNATHAN M.
Publicado em 2014

Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity

Por Judson, Patricia L., Al Sawah, Entidhar D., Marchion, Douglas C., Xiong, Yin, Bicaku, Elona, Zgheib, Nadim Bou, Chon, Hye Sook, Stickles, Xiaomang B., Hakam, Ardeshir, Wenham, Robert M., Apte, Sachin M., Gonzalez-Bosquet, Jesus, Lancaster, Johnathan M.
Publicado em 2012

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

Por MARCHION, DOUGLAS C., BICAKU, ELONA, XIONG, YIN, ZGHEIB, NADIM BOU, SAWAH, ENTIDHAR AL, STICKLES, XIAOMANG BA, JUDSON, PATRICIA L., LOPEZ, ALEX S., CUBITT, CHRISTOPHER L., GONZALEZ-BOSQUET, JESUS, WENHAM, ROBERT M., APTE, SACHIN M., BERGLUND, ANDERS, LANCASTER, JOHNATHAN M.
Publicado no Oncol Rep (2013)

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

Por MARCHION, Douglas C., XIONG, Yin, CHON, Hye Sook, SAWAH, Entidhar AL, ZGHEIB, Nadim BOU, RAMIREZ, Ingrid J., ABBASI, Forough, STICKLES, Xiaomang B., JUDSON, Patricia L., HAKAM, Ardeshir, GONZALEZ-BOSQUET, Jesus, WENHAM, Robert M., APTE, Sachin M., BERGLUND, Anders E., LANCASTER, Johnathan M.
Publicado em 2013

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer

Por ZGHEIB, NADIM BOU, XIONG, YIN, MARCHION, DOUGLAS C., BICAKU, ELONA, CHON, HYE SOOK, STICKLES, XIAOMANG BA, AL SAWAH, ENTIDHAR, JUDSON, PATRICIA L., HAKAM, ARDESHIR, GONZALEZ-BOSQUET, JESUS, WENHAM, ROBERT M., APTE, SACHIN M., CUBITT, CHRISTOPHER L., CHEN, DUNG TSA, LANCASTER, JOHNATHAN M.
Publicado em 2012

BAD-mediated apoptotic pathway is associated with human cancer development

Por STICKLES, XIAOMANG B, MARCHION, DOUGLAS C, BICAKU, ELONA, SAWAH, ENTIDHAR AL, ABBASI, FOROUGH, XIONG, YIN, ZGHEIB, NADIM BOU, BOAC, BERNADETTE M, ORR, BRIAN C, JUDSON, PATRICIA L, BERRY, AMY, HAKAM, ARDESHIR, WENHAM, ROBERT M, APTE, SACHIN M, BERGLUND, ANDERS E, LANCASTER, JOHNATHAN M
Publicado no Int J Mol Med (2015)

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival

Por BUSH, STEPHEN H., TOLLIN, SHARON, MARCHION, DOUGLAS C., XIONG, YIN, ABBASI, FOROUGH, RAMIREZ, INGRID J., ZGHEIB, NADIM BOU, BOAC, BERNADETTE, JUDSON, PATRICIA L., CHON, HYE SOOK, WENHAM, ROBERT M., APTE, SACHIN M., CUBITT, CHRISTOPHER L., BERGLUND, ANDERS E., HAVRILESKY, LAURA J., LANCASTER, JOHNATHAN M.
Publicado no Mol Clin Oncol (2016)

Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance

Por Boac, Bernadette M., Xiong, Yin, Marchion, Douglas C., Abbasi, Forough, Bush, Stephen H., Ramirez, Ingrid J., Khulpateea, Beman R., McClung, E. Clair, Berry, Amy L., Zgheib, Nadim Bou, Chon, Hye Sook, Shahzad, Mian M., Judson, Patricia L., Wenham, Robert M., Apte, Sachin M., Berglund, Anders E., Magliocco, Anthony M., Lancaster, Johnathan M.
Publicado no Gynecol Oncol (2015)

BAD phosphorylation determines ovarian cancer chemo-sensitivity and patient survival

Por Marchion, Douglas C., Cottrill, Hope M., Xiong, Yin, Chen, Ning, Bicaku, Elona, Fulp, William J., Bansal, Nisha, Chon, Hye Sook, Stickles, Xiaomang B., Kamath, Siddharth G., Hakam, Ardeshir, Li, Lihua, Su, Dan, Moreno, Carolina, Judson, Patricia L., Berchuck, Andrew, Wenham, Robert M., Apte, Sachin M., Gonzalez-Bosquet, Jesus, Bloom, Gregory C., Eschrich, Steven A., Sebti, Said, Chen, Dung-Tsa, Lancaster, Johnathan M.
Publicado em 2011